Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... the most elusive targets in cancer drug discovery," said James Bradner, MD, Division Of Hematologic Neoplasia, Dana-Farber Cancer Institute. "Our research shows, for the first time, how ...
2009 NOV 24 ... types of Opthalmic Pathology cases, including temporal arteritis, melanoma, epithelial, hematologic and soft tissue tumors of the eye, lacrimal gland pathology, eyelid skin and mucosal ...
Subject: American International Pathology Laboratories
2009 NOV 23 ... neutropenia, and anemia. Monitor blood counts and omit or modify dose for hematologic toxicities. Mucositis may occur. If = Grade 2 mucositis is observed, omit ...
2009 NOV 28 ... rash were seen in all patients, while lymphadenopathy was found in 84.4% of patients. Hematologic abnormalities were seen in 93.8% and hepatic involvement was seen in 90.4% of cases, ...
2009 NOV 23 ... research on the cloning of human antibodies and practiced oncology with a specialty in hematologic malignancies and bone marrow transplantation. Dr. Dessain is also involved in the ...
2009 NOV 23 ... of pralatrexate (FOLOTYN™, Allos Therapeutics, Inc.) in the treatment of select hematologic malignancies and solid tumors. Pralatrexate was recently approved by the ...
2009 NOV 23 ... with extramembranous and intramembranous deposition of lipids. In the absence of hematologic malignancy and in light of the abnormal lipid profile, a disorder of lipid metabolism ...
2009 NOV 23 ... Mutated and unmutated patients did not significantly differ in initial clinical or hematologic parameters. The 5-year OS was 76.9% (95% CI, 49.2%-91.3%) in mutated versus 18.3% (95% ...
2009 NOV 23 ... date, eight patients (62%) are alive, four (31%) still in CR. All patients experienced hematologic toxicity (WHO 3-4) with two deaths due to septic shock," wrote E. Cavalieri and ...
2009 NOV 23 ... "The preferentially expressed antigen in melanoma (PRAME) is expressed in several hematologic malignancies, but either is not expressed or is expressed at only low levels in normal ...
2009 NOV 23 ... (5q, CXL017), a compound with low micromolar cytotoxicity against a wide-range of hematologic and solid tumor cells. More excitingly, our studies of 5q in camptothecin (CCRF-CEM/C2) ...
2009 NOV 23 ... with a median number of 4 IP cycles (range, 0.5-7.5) completed. Grades 3 and 4 hematologic toxicities occurred in 21% of patients (n = 7), and 8 patients (24%) experienced grade 3 ...
2009 NOV 23 ... Taiwan, "The purpose of this retrospective study was to test whether the pretreatment hematologic profile can predict the prognosis of patients with head and neck cancer. Medical records ...
2009 NOV 27 ... and Environmental Health (Effects of occupational exposure to 1,4-dichlorobenzene on hematologic, kidney, and liver functions. International Archives of Occupational and Environmental ...
2009 NOV 16 ... Harvard Medical School, Dana-Farber Cancer Institute (DFCI), is Chief of the Division of Hematologic Neoplasia, Director of the Lipper Myeloma Center and Lebow Institute for Myeloma ...
2009 NOV 23 ... or ZIO-101) is a novel organic arsenic being developed for the treatment of various hematologic and solid cancers. Preclinical and clinical studies to date have demonstrated that ...
2009 NOV 23 ... or ZIO-101) is a novel organic arsenic being developed for the treatment of various hematologic and solid cancers. Preclinical and clinical studies to date have demonstrated that ...
